Home › Funds › HighVista Strategies LLC › IMVT

HighVista Strategies LLC position in IMVT

IMMUNOVANT INC · Health Care

HighVista Strategies LLC reported holding 205,954 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$7.0M, representing 1.83% of its reported portfolio and ranking #9 among its reported holdings. HighVista Strategies LLC has disclosed IMVT holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)205.95K sh
Reported value held$6.96M
Portfolio Weight1.83%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HighVista Strategies LLC's IMVT position evolved

HighVista Strategies LLC first disclosed a stake in IMVT in Q3 2023 at 106,908 shares (US$4.1M). The position peaked in Q2 2026 at 277,873 shares, worth US$10.7M. Across 9 filings, HighVista Strategies LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 205,954 shares valued at US$7.0M — a reduction of -71,919 shares quarter over quarter.. Notable position changes include a 91% increase in Q2 2025 (shares were roughly flat over the following quarter), a 38% increase in Q3 2025 (shares rose 58% over the following quarter), a 26% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 106.91K $4.10M New
Q4 2023 121.29K $5.11M Add
Q1 2025 95.65K $1.63M New
Q2 2025 182.81K $2.92M Add
Q3 2025 253.13K $4.08M Add
Q4 2025 221.88K $5.64M Reduce
Q1 2026 225.14K $5.59M Add
Q2 2026 277.87K $10.71M Add
Q3 2026 205.95K $6.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has HighVista Strategies LLC held IMVT?

HighVista Strategies LLC has disclosed IMVT holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is HighVista Strategies LLC's current position in IMVT?

As of Q3 2026, HighVista Strategies LLC holds 205.95K shares of IMVT (IMMUNOVANT INC), valued at $6.96M, representing 1.83% of its reported portfolio and ranking #9.

Has HighVista Strategies LLC been buying or selling IMVT?

In the latest 13F filing (Q3 2026), HighVista Strategies LLC reduced its position in IMVT. The position peaked in Q2 2026 at 277.87K shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.